Clinical utility of circulating tumor DNA detection for diagnosis of breast cancer / 中国癌症杂志
China Oncology
; (12): 947-951, 2016.
Article
em Zh
| WPRIM
| ID: wpr-508373
Biblioteca responsável:
WPRO
ABSTRACT
With the development of the next generation sequencing technology, considerable attention has been paid to the utility of circulating tumor DNA (ctDNA) detection in breast cancer. There are many clinical trials showed the ctDNA detection is a potential biomarker for the diagnosis, management and prognosis of breast cancer. ctDNA detection can provide a more accurate diagnosis for patients to guide clinical treatment in precision medicine era.
Texto completo:
1
Índice:
WPRIM
Tipo de estudo:
Diagnostic_studies
Idioma:
Zh
Revista:
China Oncology
Ano de publicação:
2016
Tipo de documento:
Article